Pre-Surgical Toolkit for Cancer Care
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a pre-surgical toolkit called OPTI-Surg can improve recovery for older adults with cancer after surgery. It compares usual care with two experimental groups: one using OPTI-Surg training and materials, and another adding a coach for guidance. Suitable candidates have planned surgeries, such as a gastrectomy or lung lobectomy, and are not undergoing emergency procedures. The goal is to enhance recovery and physical functioning for eligible participants. As an unphased trial, this study offers participants the chance to contribute to innovative research that could improve surgical recovery for future patients.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Pre-Surgical Toolkit (OPTI-Surg) is safe for improving surgical care in older cancer patients?
Research has shown that the Pre-Surgical Toolkit (OPTI-Surg) is generally safe for older cancer patients. Studies have found no significant negative effects from using this toolkit, and there are no reports of serious problems linked to its use. Since the toolkit primarily provides information and training, participants manage it well. Patients and healthcare providers can use it without concern for harmful side effects.12345
Why are researchers excited about this trial?
Researchers are excited about the Pre-Surgical Toolkit (OPTI-Surg) because it aims to enhance the preparation of healthcare providers before cancer surgeries, potentially improving outcomes. Unlike standard care, which often relies on established protocols, OPTI-Surg introduces specialized training and informational materials to ensure that providers are thoroughly prepared. Additionally, some providers receive coaching, offering a personalized approach to refine their skills and knowledge. This proactive method could lead to more efficient surgeries and better recovery rates for patients, making it a promising development in cancer care.
What evidence suggests that the Pre-Surgical Toolkit (OPTI-Surg) is effective for improving surgical care and outcomes in older cancer patients?
Research has shown that the Pre-Surgical Toolkit, known as OPTI-Surg, can improve surgery outcomes for older cancer patients. In this trial, healthcare providers and institutions will receive OPTI-Surg training and informational materials, with some also meeting with a coach. Studies found that patients using OPTI-Surg recovered more quickly and improved their physical abilities after surgery. Specifically, older patients who followed pre-surgery advice were more likely to return to their usual activity levels. The toolkit prepares patients before surgery, aiding in faster recovery. Early findings suggest that this method enhances overall surgical care for elderly patients.12567
Who Is on the Research Team?
George J. Chang, MD, MS
Principal Investigator
The University of Texas MD Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for older adults with cancer who are planning to undergo major surgery like liver resection or lung lobectomy. They should be aiming for a cure, able to speak English, and complete questionnaires. Those with emergency surgeries, active treatment for another primary cancer, palliative intent, or mental impairments that prevent informed consent are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Surgical Preparation
Participants receive pre-surgical recommendations and preparation materials to improve recovery and functioning after surgery
Post-Surgery Follow-up
Participants' physical function is assessed 8 weeks post-surgery using the CHAMPS questionnaire
Extended Follow-up
Participants are monitored for postoperative complications and other outcomes 12 weeks post-surgery
Long-term Follow-up
Healthcare providers/institutions are followed up 6-9 months after the last patient is registered
What Are the Treatments Tested in This Trial?
Interventions
- Pre-Surgical Toolkit (OPTI-Surg)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alliance for Clinical Trials in Oncology
Lead Sponsor
National Cancer Institute (NCI)
Collaborator